Generic drug tariffs set to skyrocket in 2028. Consumers could feel impact

touted negotiated deals with 17 drug companies that have agreed to most-favored-nation pricing deals representing 80% of brand-name drugs marketed in the United States. Those deals, however, did not include generic drugs.

Industry groups also have warned generic drug manufacturers would have a difficult time affording tariff costs. When the Trump administration continue reading …